CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Syndax's lung disease ambitions for Niktimvo end with a Phase 2 failure

Phase 2

Read the original article

Published by Endpoints News on October 13, 2026 10:25 AM

Read Original